Efficacy, Pharmacokinetic and Pharmacodynamic Evaluation of Apaziquone in the Treatment of Non-Muscle Invasive Bladder Cancer

Expert Opinion on Drug Metabolism and Toxicology - United Kingdom
doi 10.1080/17425255.2017.1341490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

Advances in Urology
GynecologyUrologyObstetrics
2012English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Prediction Tools in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Histological Variants in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2011English

Preoperative Neutrophil–lymphocyte Ratio and Fibrinogen Level in Patients Distinguish Between Muscle-Invasive Bladder Cancer and Non-Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy